Dr. Gellad Discusses Accelerated Drug Approval in Axios

April 26, 2019

What happens when drugs with accelerated approval turn out not to work? CP3 Director Walid Gellad told Axios, "If there's no proof the drug has value, then why should we pay the same as if the drug had proof of value?”